Biotechnology

Viking Therapeutics’ inventory greater than doubles as traders cheer low cost entry to weight-loss-drug craze

Moderna posts shock quarterly revenue at the same time as COVID gross sales proceed to slip

Nvidia is predicted to be the very best performer within the S&P 500 via 2025, by this measure

Abbott Laboratories says FDA unbiased panel votes to approve coronary heart machine

AbbVie lowers first-quarter steerage after closing acquisition ImmunoGen

This grouping of shares has truly stored up with the Magnificent Seven, and with lots much less danger

Why revenue hunters ought to go for dividend compounders over high-yielding shares

What to consider ‘Peak 65’

Amgen’s quarterly outcomes prime expectations regardless of Enbrel gross sales decline

AI can save us and the planet — however we would not be sensible sufficient, Roubini says